Please assess the completion status of the following clinical trial:

Trial Title: Helmet Continuous Positive Airway Pressure Versus Oxygen Venturi in Acute Respiratory Failure in CAP: CAPOVeRSO

Study Design Characteristics:
- Allocation: RANDOMIZED
- Intervention Model: PARALLEL
- Observational Model: None
- Primary Purpose: TREATMENT
- Time Perspective: None
- Masking: NONE
- Phase: None
- Number of Arms: 2.0

Eligibility Criteria:
Inclusion Criteria:~* Community-acquired pneumonia (CAP) defined as: new chest x-ray pulmonary infiltrate, fever, and respiratory symptoms~* Acute Hypoxemic Respiratory failure~* Respiratory Rate \< 35 breaths/min~* PaO2/FiO2 \> 200 and \< 300 while breathing oxygen for at least 15 minutes via a Venturi mask with FiO2 0.5~Exclusion criteria~* Immunosuppression~* acute cardiogenic pulmonary edema~* Patients belonging to Class II-III-IV of the NYHA~* Acute coronary syndrome~* Acute Respiratory Acidosis pH \< 7.35 and PaCO2 \> 45 mmHg~* More than 3 acute organ failures~* Systolic Pressure \< 90 mmHg under fluid resuscitation or vasopressor drug use~* Seizures~* Decreased level of consciousness (GCS \<12)~* Inability to clear secretions~* Pre-defined intubation criteria

- Gender: ALL
- Minimum Age: 18 Years
- Maximum Age: None
- Healthy Volunteers: f

Study Arms:
- 1 (Type: ACTIVE_COMPARATOR): CPAP delivered by a helmet
- 2 (Type: NO_INTERVENTION): O2 administration via a conventional Venturi mask

Based on this trial design, predict the completion outcome and termination type (if applicable).